Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS)
CNY 8.28
(-0.12%)
CNY 8.28
(-0.12%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.55 Billion CNY | -25.58% |
| 2022 | 1.94 Billion CNY | 16.42% |
| 2021 | 1.67 Billion CNY | 34.75% |
| 2020 | 1.27 Billion CNY | 11.07% |
| 2019 | 1.12 Billion CNY | -2.42% |
| 2018 | 1.16 Billion CNY | -0.56% |
| 2017 | 1.15 Billion CNY | 21.0% |
| 2016 | 963.88 Million CNY | 33.62% |
| 2015 | 719.56 Million CNY | 49.35% |
| 2014 | 464.07 Million CNY | 40.47% |
| 2013 | 337.66 Million CNY | 29.5% |
| 2012 | 182.39 Million CNY | -53.41% |
| 2011 | 550.13 Million CNY | 75.74% |
| 2010 | 324.91 Million CNY | 53.9% |
| 2009 | 201.62 Million CNY | 19.04% |
| 2008 | 138.33 Million CNY | -4.3% |
| 2007 | 156.03 Million CNY | 82.12% |
| 2006 | 102.71 Million CNY | 5.49% |
| 2005 | 96.96 Million CNY | 2171.21% |
| 2004 | -4.68 Million CNY | -104.78% |
| 2003 | 98 Million CNY | 6.33% |
| 2002 | 92.17 Million CNY | 43.57% |
| 2001 | 39.05 Million CNY | -29.48% |
| 2000 | 91.03 Million CNY | -9.54% |
| 1999 | 100.63 Million CNY | -9.38% |
| 1998 | 111.05 Million CNY | 13.94% |
| 1997 | 97.46 Million CNY | -14.12% |
| 1996 | 113.49 Million CNY | 12.62% |
| 1995 | 100.77 Million CNY | -23.63% |
| 1994 | 131.95 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 186.78 Million CNY | 171.13% |
| 2024 Q1 | 241.09 Million CNY | -47.67% |
| 2024 Q2 | -262.6 Million CNY | -197.42% |
| 2023 Q3 | 320.53 Million CNY | 12.87% |
| 2023 Q2 | 283.97 Million CNY | -1.55% |
| 2023 Q4 | 507.18 Million CNY | 58.23% |
| 2023 FY | - CNY | -25.58% |
| 2023 Q1 | 288.43 Million CNY | 41.21% |
| 2022 Q1 | 979.49 Million CNY | 200.74% |
| 2022 Q3 | 259.05 Million CNY | -33.82% |
| 2022 Q4 | 204.26 Million CNY | -21.15% |
| 2022 Q2 | 391.46 Million CNY | -60.03% |
| 2022 FY | - CNY | 16.42% |
| 2021 Q1 | 400.77 Million CNY | 87.48% |
| 2021 Q2 | 377.66 Million CNY | -5.77% |
| 2021 Q3 | 457.59 Million CNY | 21.17% |
| 2021 Q4 | 325.69 Million CNY | -28.82% |
| 2021 FY | - CNY | 34.75% |
| 2020 Q4 | 213.77 Million CNY | -16.61% |
| 2020 Q2 | 314.98 Million CNY | -3.7% |
| 2020 Q1 | 327.09 Million CNY | 93.07% |
| 2020 FY | - CNY | 11.07% |
| 2020 Q3 | 256.34 Million CNY | -18.62% |
| 2019 Q4 | 169.42 Million CNY | -9.5% |
| 2019 FY | - CNY | -2.42% |
| 2019 Q3 | 187.2 Million CNY | -38.43% |
| 2019 Q1 | 326.33 Million CNY | 73.09% |
| 2019 Q2 | 304.02 Million CNY | -6.84% |
| 2018 Q3 | 179.17 Million CNY | -43.57% |
| 2018 FY | - CNY | -0.56% |
| 2018 Q4 | 188.53 Million CNY | 5.22% |
| 2018 Q1 | 310.9 Million CNY | 49.99% |
| 2018 Q2 | 317.54 Million CNY | 2.13% |
| 2017 Q4 | 207.29 Million CNY | -30.44% |
| 2017 Q2 | 244.92 Million CNY | -3.41% |
| 2017 FY | - CNY | 21.0% |
| 2017 Q1 | 253.56 Million CNY | 44.36% |
| 2017 Q3 | 298.02 Million CNY | 21.68% |
| 2016 Q3 | 235.06 Million CNY | 17.96% |
| 2016 Q1 | 198.71 Million CNY | 30.87% |
| 2016 FY | - CNY | 33.62% |
| 2016 Q4 | 175.65 Million CNY | -25.27% |
| 2016 Q2 | 199.26 Million CNY | 0.28% |
| 2015 FY | - CNY | 49.35% |
| 2015 Q4 | 151.84 Million CNY | -2.27% |
| 2015 Q3 | 155.37 Million CNY | -11.03% |
| 2015 Q2 | 174.64 Million CNY | 16.23% |
| 2015 Q1 | 150.25 Million CNY | 65.33% |
| 2014 Q4 | 90.88 Million CNY | 10.63% |
| 2014 FY | - CNY | 40.47% |
| 2014 Q1 | 95.19 Million CNY | 1068.76% |
| 2014 Q2 | 89.14 Million CNY | -6.36% |
| 2014 Q3 | 82.14 Million CNY | -7.85% |
| 2013 Q2 | 63.87 Million CNY | -20.32% |
| 2013 Q3 | 90.95 Million CNY | 42.41% |
| 2013 FY | - CNY | 29.5% |
| 2013 Q4 | 8.14 Million CNY | -91.05% |
| 2013 Q1 | 80.16 Million CNY | 1161.75% |
| 2012 Q2 | 42.68 Million CNY | -20.95% |
| 2012 Q3 | 67.2 Million CNY | 57.44% |
| 2012 Q4 | 6.35 Million CNY | -90.55% |
| 2012 FY | - CNY | -53.41% |
| 2012 Q1 | 53.99 Million CNY | -85.89% |
| 2011 Q4 | 382.84 Million CNY | 1666.29% |
| 2011 Q1 | 43.07 Million CNY | -68.97% |
| 2011 Q2 | 27.76 Million CNY | -35.54% |
| 2011 Q3 | 21.67 Million CNY | -21.94% |
| 2011 FY | - CNY | 75.74% |
| 2010 Q4 | 138.81 Million CNY | 378.97% |
| 2010 Q2 | 20.34 Million CNY | -38.8% |
| 2010 FY | - CNY | 53.9% |
| 2010 Q1 | 33.24 Million CNY | 264.51% |
| 2010 Q3 | 28.98 Million CNY | 42.43% |
| 2009 Q4 | 9.12 Million CNY | -52.97% |
| 2009 Q2 | 43.27 Million CNY | 5.93% |
| 2009 Q1 | 40.85 Million CNY | 1008.25% |
| 2009 FY | - CNY | 19.04% |
| 2009 Q3 | 19.39 Million CNY | -55.18% |
| 2008 FY | - CNY | -4.3% |
| 2008 Q4 | -4.49 Million CNY | -113.59% |
| 2008 Q3 | 33.09 Million CNY | 0.27% |
| 2008 Q1 | 27.54 Million CNY | -51.08% |
| 2008 Q2 | 33 Million CNY | 19.82% |
| 2007 Q2 | 2.89 Million CNY | -88.65% |
| 2007 Q3 | 21.6 Million CNY | 645.73% |
| 2007 FY | - CNY | 82.12% |
| 2007 Q4 | 56.3 Million CNY | 160.59% |
| 2007 Q1 | 25.53 Million CNY | 226.13% |
| 2006 Q4 | -20.24 Million CNY | -148.83% |
| 2006 Q1 | 23.92 Million CNY | -3.38% |
| 2006 Q3 | 41.47 Million CNY | -30.41% |
| 2006 FY | - CNY | 5.49% |
| 2006 Q2 | 59.59 Million CNY | 149.08% |
| 2005 Q2 | 31.41 Million CNY | 55.96% |
| 2005 Q1 | 20.13 Million CNY | 128.89% |
| 2005 Q3 | 22.85 Million CNY | -27.25% |
| 2005 Q4 | 24.76 Million CNY | 8.37% |
| 2005 FY | - CNY | 2171.21% |
| 2004 Q2 | 23.59 Million CNY | -3.8% |
| 2004 FY | - CNY | -104.78% |
| 2004 Q4 | -69.7 Million CNY | -428.79% |
| 2004 Q3 | 21.19 Million CNY | -10.16% |
| 2004 Q1 | 24.52 Million CNY | -7.33% |
| 2003 Q2 | 31.64 Million CNY | 49.05% |
| 2003 Q3 | 24.03 Million CNY | -24.05% |
| 2003 Q4 | 26.46 Million CNY | 10.12% |
| 2003 FY | - CNY | 6.33% |
| 2003 Q1 | 21.23 Million CNY | 2.68% |
| 2002 Q4 | 20.67 Million CNY | 101.76% |
| 2002 Q3 | 10.24 Million CNY | -73.93% |
| 2002 Q1 | 4.32 Million CNY | 0.0% |
| 2002 FY | - CNY | 43.57% |
| 2002 Q2 | 39.31 Million CNY | 346.03% |
| 2001 FY | - CNY | -29.48% |
| 2000 FY | - CNY | -9.54% |
| 1999 FY | - CNY | -9.38% |
| 1998 FY | - CNY | 13.94% |
| 1997 FY | - CNY | -14.12% |
| 1996 FY | - CNY | 12.62% |
| 1995 FY | - CNY | -23.63% |
| 1994 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 5.54 Billion CNY | 71.898% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 3.57 Billion CNY | 56.457% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 1.12 Billion CNY | -37.973% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 192.74 Million CNY | -707.774% |
| Aurora Optoelectronics Co.,Ltd. | -509.76 Million CNY | 405.427% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | -14.11 Million CNY | 11133.084% |
| NanJing Pharmaceutical Company Limited | 1.61 Billion CNY | 3.852% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 157.93 Million CNY | -885.791% |